Trademark: 79249894
Word
MANROS THERAPEUTICS
Status Date
Tuesday, July 23, 2019
Registration Number
5809595
Registration Date
Tuesday, July 23, 2019
Filing Date
Thursday, October 18, 2018
Published for Opposition
Tuesday, May 7, 2019
5 Pharmaceutical products for the treatment of cystic fibrosis, polycystic kidney disease, Down syndrome and Alzheimer's disease; chemical preparations for medical or pharmaceutical use namely, for the treatment of cystic fibrosis, polycystic kidney disease, Down syndrome and Alzheimer's disease
42 Scientific research for medical purposes in the fields of cystic fibrosis, polycystic kidney disease, Down syndrome and Alzheimer's disease
Jan 23, 2019
Application Filing Receipt Mailed
Jan 17, 2019
Sn Assigned For Sect 66a Appl From Ib
Jan 19, 2019
New Application Office Supplied Data Entered
Jan 28, 2019
Assigned To Examiner
Jan 28, 2019
Non-Final Action Written
Jan 29, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Feb 8, 2019
Refusal Processed By Mpu
Feb 8, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Mar 2, 2019
Refusal Processed By Ib
Mar 20, 2019
Correspondence Received In Law Office
Mar 20, 2019
Teas Response To Office Action Received
Mar 21, 2019
Teas/Email Correspondence Entered
Mar 22, 2019
Assigned To Examiner
Apr 17, 2019
Notification Of Notice Of Publication E-Mailed
May 7, 2019
Published For Opposition
May 7, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 23, 2019
Registered-Principal Register
Oct 23, 2019
Final Disposition Notice Created, To Be Sent To Ib
Nov 12, 2019
Final Disposition Notice Sent To Ib
Dec 1, 2019
Final Decision Transaction Processed By Ib
Mar 22, 2019
Approved For Pub - Principal Register
Nov 12, 2019
Final Disposition Processed
Jul 23, 2024
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
